about
Early diagnosis of acute myocardial infarction using high-sensitivity troponin IDiagnosis of Myocardial Infarction Using a High-Sensitivity Troponin I 1-Hour Algorithm.Association of High-Sensitivity Cardiac Troponin I Concentration With Cardiac Outcomes in Patients With Suspected Acute Coronary Syndrome.Challenging the 99th percentile: A lower troponin cutoff leads to low mortality of chest pain patients.Discrimination of patients with type 2 myocardial infarction.Cardiovascular Biomarkers in Hypertensive Patients with Medical Treatment-Results from the Randomized TEAMSTA Protect I Trial.Effects of renal denervation on heart failure biomarkers and blood pressure in patients with resistant hypertension.Relations of Sex to Diagnosis and Outcomes in Acute Coronary Syndrome.Cardiac Troponins for the Diagnosis of Acute Myocardial Infarction in Chronic Kidney DiseaseClinical chemistry score versus high-sensitivity cardiac troponin I and T tests alone to identify patients at low or high risk for myocardial infarction or death at presentation to the emergency departmentImpact of age on the performance of the ESC 0/1h-algorithms for early diagnosis of myocardial infarctionProspective Validation of the 0/1-h Algorithm for Early Diagnosis of Myocardial InfarctionEvaluation of a new ultra-sensitivity troponin I assay in patients with suspected myocardial infarctionDiagnostic Value of Soluble Urokinase-Type Plasminogen Activator Receptor in Addition to High-Sensitivity Troponin I in Early Diagnosis of Acute Myocardial Infarction.Temporal trends in incidence and outcome of acute coronary syndromeClinical application of the 4th Universal Definition of Myocardial InfarctionHow do comorbidities influence troponin concentrations?Prognostic Value of a Novel and Established High-Sensitivity Troponin I Assay in Patients Presenting with Suspected Myocardial InfarctionReply: Hospital Charges Associated With Inpatient Troponin TestingVenoarterial Extracorporeal Membrane Oxygenation for Cardiopulmonary SupportMore evidence for high-sensitivity troponin assaysDiagnostic Evaluation of a High-Sensitivity Troponin I Point-of-Care AssayPrecursor proadrenomedullin influences cardiomyocyte survival and local inflammation related to myocardial infarctionDiagnosing myocardial infarction: a highly sensitive issueEffect of renal denervation procedure on left ventricular mass, myocardial strain and diastolic function by CMR on a 12-month follow-upHigh-sensitivity troponin I and all-cause mortality in patients with stable COPD: an analysis of the COSYCONET studyPerformance of the ESC 0/1-h and 0/3-h Algorithm for the Rapid Identification of Myocardial Infarction Without ST-Elevation in Patients With DiabetesRisk prediction of in-hospital mortality in patients with venoarterial extracorporeal membrane oxygenation for cardiopulmonary support: The ECMO-ACCEPTS scoreComparative Analysis of Circulating Noncoding RNAs Versus Protein Biomarkers in the Detection of Myocardial InjuryApplication of the SCAI classification in a cohort of patients with cardiogenic shockMachine Learning to Predict the Likelihood of Acute Myocardial InfarctionApplication of High-Sensitivity Troponin in Suspected Myocardial InfarctionPredictive value of soluble urokinase-type plasminogen activator receptor for mortality in patients with suspected myocardial infarctionApplication of a machine learning-driven, multibiomarker panel for prediction of incident cardiovascular events in patients with suspected myocardial infarction
P50
Q36319844-85A18E3B-08A7-46A5-9C78-D0DD9D25E9E2Q39580710-8C728C5E-B53A-423C-8361-4520BE36DCCBQ47414008-81186A8D-A4D1-43C5-A882-5EB30F90D32CQ47586251-691EC24B-4ED7-4F2B-A0BB-7D35E426C79BQ47613575-E66D5B01-E0C9-4B4F-8F2D-F1241575096FQ47807051-D704918A-0A7A-48F5-AD9A-BAFC2F8B7268Q48617743-E22E68DF-165B-4496-814E-4CC862A87501Q52662453-5705A976-6C24-4B6B-9B72-42D1456D96E7Q58123943-68A91DB3-1348-4E5E-8A71-4076BE77A2A5Q58765588-B93AB880-3060-4C29-AD99-6E25386388D2Q62128738-3C1C5597-454A-4FD8-A8B4-F58D29F3645BQ62128740-172336B0-9D19-476A-9A0A-10D429AE0777Q62813865-C9DA12BB-559C-4949-B12E-20EA77CA0CF6Q62813888-EEE34F73-E38E-44CC-96A5-5F77768E52C6Q89603940-DEA845C5-F1A5-4245-B803-68D4B7908816Q89799551-5DE661CD-B8BB-493F-8001-782AFD03AB40Q89899453-BB569137-4872-42D3-8411-6C700C176AFBQ90041460-B7651C71-BC92-40C6-864F-1D5FE9CB0204Q90313778-27449E98-0494-4017-BFE0-371082B6D5DBQ90668784-5A29C945-D38B-4901-9E10-105B8A774135Q90832672-9CC7BA00-F5BC-4C96-ADBF-15841E89F16BQ91171991-1E757C5E-A75C-4150-BF2C-C8CDAEE9EE18Q91239085-98EFA065-128B-48FE-8BF6-7EF17A86155CQ91253196-9C11692D-59A0-458F-98AF-6815A208836CQ91843921-175EE469-2567-41B8-8AC8-6ECCDEF60255Q91930848-12800690-98BA-445A-8B3A-F30725F3845EQ92023747-A1FCC44F-1D16-4E82-A9B7-D0BB3C59E12EQ92378574-F0F30006-138D-440F-94A1-5AB8D3094268Q92496457-BFF2AE93-01F5-4019-A9DD-164FF8E21DF9Q92569048-0FF2A343-443A-4A2F-BF90-A81AB9F43B84Q92643141-CE15F559-584B-4CA7-85EC-7CC810DD3F8EQ93047261-F11EE996-C460-4D62-B2AB-E591AE4C10EDQ93117519-450321F3-D382-4841-BA02-AF51A4DEC6F1Q95938934-8E7E3A28-7E61-43FA-AD8C-6501CBF4C5C1
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Johannes Tobias Neumann
@en
Johannes Tobias Neumann
@nl
type
label
Johannes Tobias Neumann
@en
Johannes Tobias Neumann
@nl
prefLabel
Johannes Tobias Neumann
@en
Johannes Tobias Neumann
@nl
P31
P496
0000-0002-9478-2757